Thursday, August 30, 2018

Study of rare cancer yields therapeutic clues to combat drug resistance

The team set out to explore cancer drivers that allow NUT midline carcinoma -- a rare, aggressive cancer that can arise in multiple organs -- to become impervious to drugs. Their results may apply to several forms of cancer fueled by the same mutated driver gene, and their approach may be applicable to other types of cancer whose genomes have been sequenced.

from Top Health News -- ScienceDaily https://ift.tt/2PkKInJ

No comments:

Post a Comment

Brain cancer may begin years before doctors can see it

Scientists in South Korea have discovered that one of the most common malignant brain tumors in young adults may begin years before a tumor ...